Back to WA WOLVERINE ASSET MANAGEMENT LLC
SASAREPTA THERAPEUTICS INC
Showing 2 of 22 quarters
Position history for WAWOLVERINE ASSET MANAGEMENT LLC's holdings in SAREPTA THERAPEUTICS INC
No. Wolverine Asset Management exited its SAREPTA THERAPEUTICS position in Q4 2024. Its Q3 2024 13F listed 156,000 shares worth $266,476. Wolverine Asset Management already held SAREPTA THERAPEUTICS in its Q1 2019 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$266,476
Total Shares Change
-156,000
Quarter-by-Quarter History